$18.24
▲ +0.1% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
CC: Lowering target price to $19.00
Wall Street Thinks Chemours Company (CC) Is Too Cheap To Ignore Now
3M, DuPont, Corteva, Chemours Sued by New York AG Over Toxic Pollution From Consumer Products
Overview
52-week range
$10
$29
44% of range
Avg surprise (last 3)
+64.8%
Avg reaction (last 2)
+1.3%
50% positive
Latest IV / EM
74%
EM ±4.4% · $18 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.05 | $-0.05 | +200.0% | -61.5% | +2.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.40 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.58 | $0.46 | +26.1% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.13 | $0.19 | -31.6% | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.22 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.39 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.36 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.08 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-2.52 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | $0.43 | $0.58 | -25.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $1.17B | — | $1.26B | $1.34B | $1.13B | — | $1.22B | $1.25B |
| Gross profit | $212M | — | $233M | $278M | $236M | — | $286M | $308M |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $-29M | — | $60M | $-381M | $-5M | — | $-32M | $60M |
| EPS (diluted) | $-0.19 | — | $0.40 | $-2.54 | $-0.03 | — | $-0.22 | $0.39 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $563M | $670M | $613M | $502M | $464M | $713M | $596M | $604M |
| Inventory | $1.54B | $1.57B | $1.55B | $1.56B | $1.55B | $1.46B | $1.43B | $1.36B |
| Total current assets | $2.93B | $3.00B | $3.21B | $3.10B | $2.93B | $3.02B | $3.08B | $2.94B |
| Total assets | $7.27B | $7.38B | $7.57B | $7.49B | $7.39B | $7.51B | $7.46B | $7.25B |
| Long-term debt | $4.10B | $4.10B | $4.10B | $4.10B | $4.06B | $4.05B | $3.99B | $3.95B |
| Total liabilities | $7.05B | $7.13B | $7.27B | $7.25B | $6.81B | $6.92B | $6.81B | $6.53B |
| Total equity | $215M | $250M | $298M | $237M | $579M | $587M | $643M | $714M |